Closing remarks - Vascular protection in CAD and PAD through factor Xa inhibition... The COMPASS study.

29 August 2017 (16:14 - 16:15)

Organised by:

About the speakers

Doctor Stuart J Connolly

McMaster University, Hamilton (Canada)

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

3 More presentations in this session

Opening remarks - Vascular protection in CAD and PAD through factor Xa inhibition... The COMPASS study.

Doctor S. Yusuf (Hamilton, CA)

The COMPASS study... From start to stop.

Doctor S. Connolly (Hamilton, CA) Doctor J. Eikelboom (Hamilton, CA)

Interactive discussions and questions - Vascular protection in CAD and PAD through factor Xa inhibition... The COMPASS study.

Professor D. Bhatt (New York City, US) Professor P. Steg (Paris, FR) Doctor J. Eikelboom (Hamilton, CA) Doctor S. Connolly (Hamilton, CA) Doctor S. Yusuf (Hamilton, CA)

Access the full session

Vascular protection in coronary artery disease (CAD) and peripheral artery disease (PAD) through factor Xa inhibition... The COMPASS study

The Event

ESC Congress 2017

29 August 2017 16:14 CET

You may be interested in

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

19 July 2023

Congress Presentation

Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial

1 September 2024

Congress Presentation

Conclusion

30 August 2025

Congress Presentation

Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

30 August 2020

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

ESC 365 is supported by

Explore sponsored resources